Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28916596 | 0.85 | — | — | |
| SCHEMBL14700298 | 0.80 | CYP4F2 (0.30) | — | |
| SCHEMBL13661677 | 0.80 | — | — | |
| Phosphine SCHEMBL23282455 | 0.79 | LMNA (0.44) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL21313383 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL28722393 | 0.71 | — | — | |
| SCHEMBL28728010 | 0.70 | TSHR (0.42) | — | |
| SCHEMBL571531 | 0.70 | TSHR (0.42) | — | |
| SCHEMBL30151492 | 0.70 | TSHR (0.39) | ALDH1A1 | |
| SCHEMBL26416994 | 0.69 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8778864-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-8455418-B2 | Polyglyceryl compounds comprising a methyl glucoside or sorbitan remnant and compositions containing same | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-8394755-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2013-03-12 | — | — | US | disclosed |
| EP-2491916-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2491917-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2491918-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| US-8211850-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120122758-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
| US-20120122755-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC. | 2012-05-17 | — | — | US | disclosed |
| US-20120123103-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | ALDH1A1 4219/4885SMN1; SMN2 3549/4885 |
| US-20120122755-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | ALDH1A1 4219/4885SMN1; SMN2 3549/4885 |
| US-20120122758-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | ALDH1A1 4219/4885SMN1; SMN2 3549/4885 |
| US-20120123103-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | ALDH1A1 4219/4885SMN1; SMN2 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.